Our cohort consisted of 82,717 patients newly diagnosed with COPD. During a total follow-up of 274,025 patient-years, there were 6,234 CVEs, for a rate of 2.2 CVEs per 100 patient-years.

Two formulations of ipratropium for COPD were also compared in a one-year, open-label safety and effectiveness study (NCT02194205), with comparable results. Atrovent HFA, an inhalation aerosol, was ...

However, also like Primatene, Asthmanefrin was significantly less effective at controlling asthma symptoms than prescription albuterol. Primatene Mist inhalers provide temporary relief from mild, ...

After reformulating with HFA propellant and changing the inhaler device, Primatene Mist became available OTC again in 2018.

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.

However, the market for all inhalation-related diseases, specifically idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), plus COPD and asthma, amounted to $28.1 billion in 2015 and is ...

Bronchodilators to open the airways (e.g., albuterol or ipratropium bromide and albuterol) Untreated anaphylaxis can lead to hypotension (low blood pressure), incontinence, fainting, shock ...

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management ...